Congenital disorders sharing oxidative stress and cancer proneness as phenotypic hallmarks: Prospects for joint research in pharmacology

Medical Hypotheses

Volumn 51, Issue 3, 1998, Pages 253-266

  Pagano, G ^a   Korkina, L G ^b   Brunk, U T ^c   Chessa, L ^d   Degan, P ^e   Del Principe, D ^f   Kelly, F J ^g   Malorni, W ^h   Pallardo F ⁱ   Pasquier, C ^j   Scovassi, I ^k   Zatterale, A ^l   Franceschi, C ^m  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Institute of Paediatric Haematology   (Russian Federation)

^c LINKÖPING UNIVERSITY   (Sweden)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY OF GENOA   (Italy)

^f 2nd Rome University Medical School   (Italy)

^g ST THOMAS HOSPITAL   (United Kingdom)

^h ISTITUTO SUPERIORE DI SANITÀ   (Italy)

ⁱ UNIVERSITY OF VALENCIA   (Spain)

^j Section of Radiology   (France)

^k CNR   (Italy)

^l Unit of Cytogenetics   (Italy)

^m UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; FREE RADICAL; REACTIVE OXYGEN METABOLITE;

AGING; ANEMIA; ATAXIA TELANGIECTASIA; CANCER RISK; CARCINOGENESIS; CYSTIC FIBROSIS; DOWN SYNDROME; HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; XERODERMA PIGMENTOSUM;

EID: 13144267694     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(98)90084-6     Document Type: Article

References (163)

1. Ames B N. Endogenous oxidative DNA damage, aging, and cancer. Free Rad Res Commun 1989; 7: 121-128.
2. Brown R K, Kelly F J. Evidence for increased oxidative damage in patients with cystic fibrosis. Pediatr Res 1994; 36: 487-493.
3. Crawford D, Zbinden I, Monet R, Cerutti P. Antioxidant enzymes in xeroderma pigmentosum fibroblasts. Cancer Res 1988; 48: 2132-2134.
4. Emerit I, Cerutti P. Clastogenic activity from Bloom's syndrome fibroblast cultures. Proc Natl Acad Sci USA 1981; 78: 1868-1872.
5. Emerit I. Reactive oxygen species, chromosome mutation and cancer: Possible role of clastogenic factors in carcinogenesis. Free Rad Biol Med 1994; 16: 99-109.
6. Epstein C J, Avraham K B, Lovett M et al. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: Animal model of dosage effects in Down syndrome Proc Natl Acad Sci USA 1987; 84: 8044-8048
7. Freeman B A, Crapo J D. Biology of diseases: free radicals and tissue injury. Lab Invest 1982; 47: 412-426.
8. Gotz M E, Kunig G, Riederer P, Youdim M B. Oxidative stress: free radical production in neural degeneration. Pharmacol Ther 1994; 63: 37-122.
9. Grinberg L N, Rachmilewitz E A, Kitrossky N, Chevion M. Hydroxyl radical generation in β-thalassemic red blood cells. Free Rad Biol Med 1995; 18: 611-615.
10. Groner Y, Elroy-Stein O, Avraham K B et al. Cell damage by excess CuZnSOD and Down's syndrome. Biomed Pharmacother 1994; 48: 231-240.
11. Hebbel R P, Ney P A, Foker W. Autoxidation, dehydration, and adhesivity may be related abnormalities of sickle erythrocytes. Am J Physiol 1989; 256: C579-C583.
12. Heim S, Johansson B, Mertens F. Constitutional chromosome instability and cancer risk. Mutat Res 1989; 221: 39-51.
13. Hoehn K, Kubbies M, Poot M, Rabinovitch P S. BrdU-Hoechst flow cytometry links the cell kinetic defect of Fanconi's anemia to oxygen hypersensitivity. In: Schroeder-Kurt T M, Auerbach A D, Obe G, eds. Fanconi Anemia: Clinical, Cytogenetic and Experimental Aspects. Berlin: Springer-Verlag, 1989: 161-173.
14. Joenje H, Arwert F, Eriksson A W, de Koning H, Oostra A B. Oxygen-dependence of chromosomal aberrations in Fanconi's anaemia. Nature 1981; 290: 142-143.
15. Kedziora J, Bartosz G. Down's syndrome: A pathology involving the lack of balance of reactive oxygen species. Free Rad Biol Med 1988; 4: 317-330.
16. Korkina L G, Samochatova E V, Maschan A A, Suslova T B, Cheremisina Z P, Afanas'ev I B. Release of active oxygen radicals by leukocytes of Fanconi's anemia patients. J Leukocyte Biol 1992; 52: 357-362.
17. Langley S C, Brown R K, Kelly F J. Reduced free-radical-trapping capacity and altered plasma antioxidant status in cystic fibrosis. Pediatr Res 1993; 33: 247-250.
18. Monboisse J-C, Borel J-P. Oxidative damage to collagen. In: Emerit I, Chance B, eds. Free Radicals and Aging. Basel: Birkhäuser, 1992: 323-327.
19. Nicotera T M, Notaro J, Notaro S, Schumer J, Sandberg A A. Elevated superoxide dismutase in Bloom's syndrome: a genetic condition of oxidative stress. Cancer Res 1989; 49: 5239-5243.
20. Nordenson I. Effect of superoxide dismutase and catalase on spontaneously occurring chromosome breaks in patients with Fanconi's anemia. Hereditas 1977; 86: 147-150.
21. Poot M, Hoehn H, Nicotera T M, Rüdiger H W. Cell kinetic evidence suggests elevated oxidative stress in cultured cells of Bloom's syndrome. Free Rad Res Commun 1989; 7: 179-187.
22. Reyes J, Salim-Hanna M, Lissi E A, Videla L A, Holmgren J. Enhanced urinary spontaneous chemiluminescence in Duchenne muscular dystrophy. Free Rad Biol Chem 1994; 16: 851-853.
23. Richter C. Oxidative damage to mitochondrial DNA and its relationship to ageing. Int J Biochem Cell Biol 1995; 27: 647-653.
24. Rumyantsev A G, Samochatova E V, Afanas'ev I B et al. The role of free oxygen radicals in the pathogenesis of Fanconi's anemia (in Russian). Ter Arkh 1989; 61: 32-36.
25. Sacks T, Moldow C F, Craddock P R, Bowers T K, Jacob H S. Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes: an in vitro model of immune vascular damage. J Clin Invest 1978; 61: 1161-1167
26. Scharffetter-Kochanek K, Wlaschek M, Briviba K, Sies H. Singlet oxygen induces collagenase expression in human fibroblasts. FEBS Lett 1993; 331: 304-306.
27. Schindler D, Hoehn H. Fanconi anemia mutation causes cellular susceptibility to ambient oxygen. Am J Hum Genet 1988; 43: 429-435.
28. Sheridan III R B, Huang P C. Superoxide dismutase and catalase activities in ataxia telangiectasia and normal fibroblast cell extracts. Mutat Res 1979; 61: 381-386.
29. Sinet P M, Allard D, Lejeune J, Jerome H. Augmentation d' activité de la superoxide dismutase erythrocytaire dans la trisomie pour le chromosome 21. C R Acad Sci 1974; D 278: 3267-3270.
30. Vercellotti G, Stroncek D, Jacob H S. Granulocyte oxygen radicals as potential suppressors of hemopoiesis: potentating roles of lactoferrin and elastase; inhibitory role of oxygen radical scavengers. Blood Cells 1987; 13: 199-206.
31. Vuillaume M. Reduced oxygen species, mutation, induction and cancer initiation. Mutat Res 1987; 186: 43-72.
32. Ward P A, Till G O, Gannon D E, Varani J A, Johnson K J. The role of iron in injury of endothelial cells in vitro and in vivo. In: Simic M G, Taylor K A, Ward J F, von Sonntag C, eds. Oxygen Radicals in Biology and Medicine. New York: Plenum, 1988: 969-974.
33. Weitzman S A, Weitberg A B, Clark E P, Stossel T P. Phagocytes as carcinogens: malignant transformation produced by human neutrophils. Science 1985; 227: 1231-1233.
34. Weitzman S A, Gordon L I. Inflammation and cancer: Role of phagocyte-generated oxidants in carcinogenesis. Blood 1990; 76: 655-664.
35. Young I S, Trouton T G, Torney J J, McMaster D, Callender M E, Trimble E R. Antioxidant status and lipid peroxidation in hereditary haemochromatosis. Free Rad Biol Med 1994; 16: 393-397.
36. Zdolsek J M, Svensson I. Effect of reactive oxygen species on Iysosomal membrane integrity: a study of lysosomal fraction. Vircbovs Arch B Cell Pathol 1993; 64: 401-406.
37. Sen C K, Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 1996; 10: 709-720.
38. Gatti R A, Berkel F, Boder E et al. Localisation of an ataxia-telangectasia gene to chromosome 11q22-23. Nature 1988; 336: 577-580.
39. Savitsky K, Bar-Shira A, Gilad S et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995; 268: 1749-1753.
40. Kerem B, Rommens J M, Buchnan J A et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989; 245: 1073-1080.
41. Strathdee C A, Gavish H, Shannon W R, Buchwald M. Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature 1992; 356: 763-767.
42. Lo Ten Fo J R, Rooismans M A, Bosnoyan-Collins L. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA Nature Genet 1996; 14: 320-323.
43. The Fanconi amaemia/Breast cancer consortium. Positional cloning of the Fanconi anaemia group A gene. Nature Genet 1996; 14: 324-328.
44. Blease R M. Progress toward gene therapy. Clin Immunol Immunopathol 1991; 61: 47-55.
45. Walsh C E, Nienhuis R J, Samulski R et al. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector. J Clin Invest 1994; 94: 1440-1448.
46. Ambrosio G, Golino P, Pascucci I et al. Modulation of platelet function by reactive oxygen metabolites. Am J Physiol 1994; 267: H308-318
47. Bengtsson T, Grenegård M. Platelets amplify chemotactic peptide-induced changes in F-actin and calcium in human neutrophils. Eur J Cell Biol 1994; 63: 345-349.
48. Bengtsson T, Zalavary S, Stendhal O, Grenegård M. Release of oxygen metabolites from chemattractant-stimulated neutrophils is inhibited by resting platelets: role of extracellular adenosine and actin polymerization. Blood 1996; 87: 4411-4423.
49. Brown R K, McBurney A, Lunec J, Kelly F J. Oxidative damage to DNA in patients with cystic fibrosis. Free Rad Biol Med 1995; 18: 801-806.
50. Busciglio J, Yankner B A. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 1995; 378: 776-779.
51. Carlsson L M, Jonsson J, Edlund T, Marklund S L. Mice lacking extracellular superoxide dismutase are more sensitive to hyperoxia. Proc Natl Acad Sci USA 1995; 92: 6264-6268.
52. Carney J M, Smith C D, Carney A M, Butterfield D A. Aging- and oxygen-induced modifications in brain biochemistry and behavior. Ann NY Acad Sci 1994; 738: 44-53.
53. Degan P, Bonassi S, De Caterina M et al. In vivo accumulation of 8-hydroxy-2-deoxyguanosine in DNA correlates with release of reactive oxygen species in Fanconi's anaemia families. Carcinogenesis 1995; 16: 735-742.
54. De La Asuncion J G, Millan A, Pla R et al. Mitochondrial glutathione oxidation correlates with age-associated oxidative damage to mitochondrial DNA. FASEB J 1996; 10: 333-338.
55. Dhôte-Burger P, Vuilleminot A, Lecompte T et al. Neutrophil degranulation related to the reperfusion of ischemic human heart during cardiopulmonary bypass. J Cardiovasc Pharmacol 1995; 25(Suppl. 2): S124-S129.
56. Driggers W J, Grishko V I, LeDoux S P, Wilson G L. Defective repair of oxidative damage in the mitochondrial DNA of a xeroderma pigmentosum group A cell line. Cancer Res 1996; 56: 1262-1266.
57. Emerit I, Levy A, Pagano G, Pinto L, Calzone R, Zatterale A. Transferable clastogenic activity in plasma from patients with FA. Hum Genet 1995; 96: 14-20.
58. Hiraishi H, Terano A, Razandi M et al. Reactive oxygen metabolite-induced toxicity to cultured bovine endothelial cells: status of cellular iron in mediating injury. J Cell Physiol 1994; 160: 160-140.
59. Huang R P, Wu J X, Fan Y, Adamson E D. UV activates growth factor receptors via reactive oxygen intermediates. J Cell Biol 1996; 133: 211-220.
60. Laskin D L, Soltys R A, Berg R A, Riley D J. Activation of alveolar macrophages by native and synthetic collagen-like polypeptides. Am J Respir Cell Mol Biol 1994; 10: 58-64.
61. Loft S, Fischer-Nielsen A, Jeding I B, Vistisen K, Enghusen Poulsen H. 8-Hydroxydeoxy-guanosine as a urinary biomarker of oxidative DNA damage. J Toxicol Environ Health 1993; 40: 391-404.
62. Monti D, Troiano L, Tropea F. Apoptosis - programmed cell death: a role in the aging process? Am J Clin Nutr 1992; 55: 1208S-1214S.
63. Panasyuk A, Frati E, Ribault D, Mitrovic D. Effects of reactive oxygen species on the biosynthesis and structure of newly synthesized proteoglycans. Free Rad Biol Med 1994; 16: 157-167.
64. Poot M, Gross O, Epe B, Pflaum M, Hoehn H. Cell cycle defect in connection with oxygen and iron sensitivity in Fanconi anemia lymphoblastoid cells. Exp Cell Res 1996; 222: 262-268.
65. Portal B C, Richard M J, Faure H S, Hadjian A J, Favier A E. Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr 1995; 61: 843-847.
66. Satoh M S, Jones C J, Wood R D, Lindahl T. DNA-excision repair defect of xeroderma pigmentosum prevents removal of a class of oxygen free radical-induced base lesions. Proc Natl Acad Sci USA 1993; 90: 6335-6339.
67. Schulz J C, Shahidi N T. Tumor necrosis factor-α overproduction in Fanconi's anemia. Am J Hematol 1993; 42: 196-201.
68. Sellak H, Franzini E, Hakim J, Pasquier C. Reactive oxygen species rapidly increase endothelial ICAM-1 ability to bind neutrophils without detectable upregulation. Blood 1994; 83: 2669-2677.
69. Takeuchi T, Morimoto K. Increased formation of 8-hydroxy-deoxyguanosine, an oxidative DNA damage, in lymphoblasts from Fanconi's anemia patients due to possible catalase deficiency. Carcinogenesis 1993; 14: 1115-1120.
70. Verity M A. Oxidative damage and repair in the developing nervous system. Neurotoxicology 1994; 15: 81-91.
71. Vina J, Vento M, García-Sala F et al. L-cysteine and glutathione metabolism are impaired in premature infants due to cystathionasedeficiency. Am J Clin Nutr 1995; 61: 1067-1069.
72. Ward A J, Olive P L, Burr A H, Rosin M P. Response of fibroblast cultures from ataxia telangiectasia patients to reactive oxygen species generated during inflammatory reactions. Environ Mol Mutagen 1994; 24: 103-111.
73. Wiseman H, Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J 1996; 313: 17-29.
74. Yang K D, Augustine N H, Shaio M-F, Bohnsack J F, Hill H R. Effects of fibronectin on actin organization and respiratory burst activity in neutrophils, monocytes and macrophages. J Cell Physiol 1994; 158: 347-353.
75. Amstad P, Moret R, Cerutti P. Glutathione peroxidase compensates for the hypersensitivity of Cu,Zn-superoxide dismutase overproduces to oxidant stress. J Biol Chem 1994; 269: 1606-1609.
76. Bar-Peled O, Kerkotian E, Segal M, Groner Y. Constitutive overexpression of Cu/Zn superoxide dismutase exacerbates kainic acid-induced apoptosis in transgenic-Cu/Zn superoxide dismutase neurons. Proc Natl Acad Sci USA 1996; 93: 8530-8535.
77. Hirose K, Longo D L, Oppenheim J J, Matsushima K. Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anticancer drugs, and ionizing radiation. FASEB J 1993; 7: 361-368.
78. Li Y, Huang T T, Carlson E J. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nature Genet 1995; 11: 376-381.
79. 2 cells confers protection from oxidative damage. Free Rad Biol Chem 1993; 15: 581-588.
80. Mirault M E, Tremblay A, Furling D et al. Transgenic glutathione peroxidase mouse models for neuroprotection studies. Ann NY Acad Sci 1994; 738: 104-115.
81. Mirochnitchenko O, Inouye M. Effect of overexpression of human Cu,Zn superoxide dismutase in transgenic mice on macrophage functions. J Immunol 1996; 156: 1578-1586.
82. Peled-Kamar M, Lotem J, Okon E, Sachs L, Groner Y. Thimic abnormalities and enhanced apoptosis of thymocytes and bone marrow cells in transgenic mice overexpressing Cu/ Zn-superoxide dismutase: implications for Down syndrome. EMBO J 1995; 14: 4985-4993.
83. Biggs B G, Vaughan W, Colombo J L, Sanger W, Purtilo D T. Cystic fibrosis complicated by acute leukemia. Cancer 1986; 57: 2441-2443.
84. Davis T M, Sawicka E H. Adenocarcinoma in cystic fibrosis. Thorax 1985; 40: 199-200.
85. Ray J H, German J. The cytogenetics of the 'chromosome-breakage syndrome'. In: German J, ed. Chromosome Mutation and Neoplasia. New York: Alan R. Liss, 1983; 135-168.
86. Cohen M M, Simpson S J, Pazos L. Specificity of bleomycininduced cytotoxic effects on ataxia telangiectasia lymphoid cell lines. Cancer Res 1981; 41: 1817-1823.
87. Auerbach A D, Wolman S R. Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens. Nature 1978; 261: 494-496.
88. Schroeder T M, German J. Bloom's Syndrome and Fanconi's anaemia: demonstration of two distinctive patterns of chromosome disruption and rearrangement. Hum Genet 1974; 25: 299-306.
89. Lett J T. Double strand breakage in DNA and cellular radiation sensitivity: linear energy transfer and the oxygen effect. In: Simic M G, Taylor K A, Ward J F, von Sonntag C, eds. Oxygen Radicals in Biology and Medicine. New York: Plenum, 1988: 419-428.
90. Gutteridge J M C, Quinlan G J, Wilkins S. Mitomycin C-induced deoxyribose degradation inhibited by superoxide dismutas: a reaction involving iron, hydroxyl and semiquinone radicals. FEBS Lett 1984;167: 37-41.
91. Pritsos C A, Sartorelli A C. Generation of reactive oxygen radicals through bioactivation of mitomycin antibiotics. Cancer Res 1986; 46: 3528-3532.
92. 2 phase. Mutat Res 1989; 218: 165-170.
93. Dallapiccola B, Porfirio B, Mokini V, Alimena G, Isacchi G, Gandini E. Effect of oxidants and antioxidants on chromosomal breakage in Fanconi's anemia lymphocytes. Hum Genet 1985; 69: 62-65.
94. Joenje H, Oostra A B. Clastogenicity of cyclophosphamide in Fanconi's anemia lymphocytes without exogenous metabolic activation. Cancer Genet Cytogenet 1986; 22: 339-345.
95. Joenje H, Gille, J J P. Oxygen metabolism and chromosomal breakage in Fanconi's anemia. In: Schroeder-Kurt T M, Auerbach A D, Obe G, eds. Fanconi Anemia: Clinical, Cytogenetic and Experimental Aspects. Berlin: Springer-Verlag, 1989: 174-181.
96. Nagasawa H, Little J B. Suppression of cytotoxic effect of mitomycin-C by superoxide dismutase in Fanconi's anemia and dyskeratosis congenita fibroblasts. Carcinogenesis 1983; 4: 795-798.
97. Nishigori C, Miyachi Y, Imamura S, Takebe H. Reduced superoxide dismutase activity in xeroderma pigmentosum fibroblasts. J Invest Dermatol 1989; 93: 506-510.
98. Poot M, Rabinovitch P S, Hoehn H. Bromodeoxyuridine amplifies free-radical-mediated DNA damage. Biochem J 1989; 261: 269-271.
99. Porfirio B, Ambroso G, Giannella G, Isacchi G, Dallapiccola B. Partial correction of chromosome instability in Fanconi anemia by desferrioxamine. Hum Genet 1989; 83: 49-51.
100. Raj A D, Heddle J A. The effect of superoxide dismutase, catalase and L-cysteine on spontaneous and mitomycin C induced chromosomal breakage in Fanconi's anemia and normal fibroblasts as measured by the micronucleus method. Mutat Res 1980; 78: 59-66.
101. Rosin M P, German J. Evidence for chromosomal instability in vivo in Bloom's syndrome: increased numbers of micronuclei in exfoliated cells. Hum Genet 1985; 71: 187-191.
102. Rosselli F, Moustacchi E. Partial correction of chromosome instability in Fanconi anemia by desferrioxamine. Hum Genet 1990; 84: 581-583.
103. Scarpa M, Rigo A, Momo F, Isacchi G, Novelli G, Dallapiccola B. Increased rate of superoxide generation in Fanconi anemia erythrocytes. Biochem Biophys Res Commun 1985; 130: 127-132.
104. Shiloh Y, Tabor E, Becker Y. Abnormal response to ataxia telangiectasia cells to agents that break the deoxyribose moiety of DNA via a targeted free radical mechanism. Carcinogenesis 1983; 4: 1317-1322.
105. 2 chromosomal radiosensitivity in families with ataxia telangiectasia. Hum Genet 1985; 84: 15-18.
106. Vuillaume M, Calvayrac R, Best-Belpomme M et al. Deficiency in the catalase activity of xeroderma pigmentosum cells and simian virus 40-transformed human cell extracts. Cancer Res 1986; 46: 538-544.
107. Fanconi G. Familiäre infantile perniziosaartige Anämie (perniziäses Blutbild und Konstitution). Jb Kinderheilkd 1927;117:257-281.
108. Joenje H, Lo Ten Foe J R, Oostra A B et al. Classification of Fanconi anemia patients by complementation analysis: evidence for a fifth genetic subtype. Blood 1995; 86: 2156-2160.
109. Joenje H. Fanconi anaemia complementation groups in Germany and the Netherlands. Hum Genet 1996; 97: 280-282
110. Liu J M, Buchwald M, Walsh C E, Young N S. Fanconi anemia and novel strategies for therapy. Blood 1994; 84: 3995-4007.
111. Pronk J C, Gibson R A, Savoia A et al. Localisation of the Fanconi anaemia complementation group A gene to chromosome 16q24.3. Nature Genet 1995; 11: 338-340.
112. Savoia A, Zatterale A, Del Principe D, Joenje H. Fanconi anaemia in Italy: high prevalence of complementation group A in two geographic clusters. Hum Genet 1996; 97: 599-603.
113. Yamashita T, Barber D L, Zhu Y, Wu N, D'Andrea A D. The Fanconi anemia polypeptide FACC is localized to the cytoplasm. Proc Natl Acad Sci USA 1994; 91: 6712-6716.
114. Youssoufian H. Localization of Fanconi anemia C protein to the cytoplasm of mammalian cells. Proc Natl Acad Sci USA 1994; 91: 7975-7979.
115. Youssoufian H. Cytoplasmic localization of FAC is essential for the correction of a prerepair defect in Fanconi anemia group C cells. J Clin Invest 1996; 97: 2003-2010.
116. 2 as determined by alkaline elution. Biochim Biophys Acta 1982; 698: 237-242.
117. Joenje H, Youssoufian H, Kruyt F A E, dos Santos C, Wevrick R, Buchwald M. Expression of the Fanconi anemia gene FAC in human cell lines: lack of effect of oxygen tension. Blood Cells Mol Dis 1995; 21: 182-191.
118. 2 on Fanconi's anaemia cells. [Abstr] Proc 24th Congr Int Soc Haematol 1992; 523.
119. Gordon-Smith E C, Rutherford T R. Fanconi anemia: constitutional aplastic anemia. Semin Hematol 1991; 28: 104-112.
120. 2 integrin. J Leukoc Biol 1991; 50: 373-380.
121. Louis-Bar D. Sur un syndrome progressif comprenant des télangiectasies capillaries cutanées et conjonctivales symétriques, à disposition naevoide et des troubles cérébelleux. Confin Neurol 1941; 4: 3242.
122. Meredith M J, Dodson J L. Impaired glutathione biosynthesis in cultures of human ataxia telangiectasia cells. Cancer Res 1987; 47: 4576-4581.
123. Yi M, Rosin M P, Anderson C K. Response of fibroblast cultures from ataxia-telangiectasia patients to oxidative stress. Cancer Lett 1990; 54: 43-50.
124. Lehmann A. The molecular biology of nucleotide excision repair and double-strand break repair in eukaryotes. In: Setlow J K, ed. Genetic Engineering. New York: Plenum Press, 1995: 1-19.
125. Friedberg E C, Walker G A, Siede W. DNA repair and mutagenesis. Washington, DC: ASN Press, 1995.
126. Vuillaume M, Daya-Grosjean L, Vicens P et al. Striking differences in cellular catalase activity between two DNA repair-deficient diseases: xeroderma pigmentosum and trichothiodystrophy. Carcinogenesis 1992;13: 321-328.
127. Satoh M, Lindahl T. Enzymatic repair of oxidative DNA damage. Cancer Res 1994; 54: 1899-1901.
128. German J, Bloom D, Passarge E. Bloom's syndrome. VII Progress Report for 1978. Clin Genet 1979; 15: 361-367.
129. Brooksbank B W, Balasz R. Superoxide dismutase, glutathione peroxidase and lipoperoxidation in Down's syndrome fetal brain. Exp Brain Res 1984; 16: 37-44.
130. Cossarizza A, Ortolani C, Forti E et al. Age-related expansion of functionally inefficient cells with markers of natural killer activity in Down's syndrome. Blood 1991; 77: 1263-1270.
131. Epstein C J, Cox D R, Epstein L B. Mouse trisomy 16: an animal model of human trisomy 21 (Down syndrome). Ann NY Acad Sci 1985; 450: 157-168.
132. Feaster W W, Kwok L W, Epstein C J. Dosage effects of superoxide dismutase-1 in nucleated cells aneuploid for chromosome 21. Am J Hum Genet 1977; 29: 563-574.
133. Reaume A G, Elliott J L, Hoffman E K et al. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nature Genet 1996;13: 43-47.
134. Ratan R R, Baraban J M. Apoptotic death in an in vitro model of neuronal oxidative stress. Clin Exp Pharmacol Physiol 1995; 22: 309-310.
135. Bye A M E, Muller D P R, Wilson J, Wright V M, Mearns M B. Symptomatic vitamin E deficiency in cystic fibrosis. Arch Dis Child 1985; 60: 162-164.
136. Kneepkens C M F, Lepage G, Smith L et al. Low beta-carotene may contribute to the accumulation of free radicals in cystic fibrosis. Pediatr Res 1991; 29: 106A.
137. Brown R K, Wyatt H, Price J F, Kelly F J. Pulmonary dysfunction in cystic fibrosis is associated with oxidative stress. Eur Resp J 1996; 9: 334-339.
138. Bilton D, Seabra L, Jones M, Webb A K, Braganza J M. High breath pentane levels in patients with cystic fibrosis. Clin Sci 1990: 79: 20P.
139. Degan P, Shigenaga M K, Park E M, Alperin P E, Ames B N. Immunoaffinity isolation of urinary 8-hydroxy-2′-deoxyguanosine and 8-hydroxyguanine and quantitation of 8-hydroxy-2′-deoxyguanosine in DNA by polyclonal antibodies. Carcinogenesis 1991; 12: 865-871.
140. Floyd R A. The role of 8-hydroguanine in carcinogenesis. Carcinogenesis 1990; 9: 1447-1450.
141. Fraga C G, Shigenaga M K, Park J-W, Degan P, Ames B N. Oxidative damage to DNA during aging, 8-hydroxy-2′-deoxyguanosine in rat organ DNA and urine. Proc Natl Acad Sci USA 1990; 87: 4533-4537.
142. Frenkel K. Oxidation of DNA bases by tumor promoter-activated processes. Environ Health Persp 1989; 81: 45-54.
143. Jacobson M D. Reactive oxygen species and programmed cell death. TIBS 1996; 21: 83-86.
144. Reed J C. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994; 124: 1-6.
145. Rosselli F, Ridet A, Soussi T, Duchaud E, Alapette C, Moustacchi E. p53-dependent pathway of radio-induced apoptosis is altered in Fanconi anemia. Oncogene 1995; 10: 9-17.
146. Woodman R C, Ruedi J M, Jesaitis A J et al. Respiratory burst oxidase and three of four oxidase-related polypeptides are associated with the cytoskeleton of human neutrophils. J Clin Invest 1991; 87: 1345-1351.
147. Palluy O, Morlière L, Gris J C, Bonne C, Modat G. Hypoxia/ reoxygenation stimulates endothelium to promote neutrophil adhesion. Free Rad Biol Med 1992; 13: 21-30.
148. Stroncek D F, Vercellotti G M, Huh P W, Jacob H S. Neutrophil oxidants inactivate alpha-1-protease inhibitors and promote PMN-mediated detachment of cultured endothelium: protection by free methionine. Arteriosclerosis 1986; 6: 332-340.
149. 2+-dependent adhesion of activated platelets to many different types of leukocytes: detection by flow cytometry. Blood 1992; 80: 134-142.
150. Del Principe D, Menichelli A, Di Giulio S et al. Stimulated platelets release factor(s) affecting the in vitro response of human polymorphonuclear cells. J Leukoc Biol 1990; 48: 7-14.
151. Zdolsek J M, Roberg K, Brunk U T. Visualization of iron in cultured macrophages: a cytochemical light and electron microscopic study using autometallography. Free Rad Biol Med 1993; 15: 1-11.
152. Öllinger K, Brunk U T. Cellular injury induced by oxidative stress is mediated through lysosomal damage. Free Rad Biol Med 1995; 19: 565-574.
153. Brunk U T, Zhang H, Roberg K, Ollinger K. Lethal hydrogen peroxide toxicity involves lysosomal iron-catalyzed reactions with membrane damage. Redox Rep 1995; 1: 267-277.
154. Olsson G M, Brunmark A, Brunk U T. Acridine orange-mediated photodamage of microsomal and lysosomal fractions. Virchows Arch B Cell Pathol 1989; 56: 247-257.
155. Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C. A new method for the cytofuorometric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′-tetrachloro-1,1′,3,3′- tetraethylbenzamidazolcarbo-cyanine iodide (JC-1). Biochem Biophys Res Commun 1993; 197: 40-45.
156. Malorni W, Rivabene R, Straface E et al. 3-aminobenzamide protects from UVB-induced apoptosis by acting on cytoskeleton and substrate adhesion. Biochem Biophys Res Comms 1995; 207: 715-724.
157. Malorni W, Straface E, Donelli G, Giacomoni G U. UV-induced cytoskeletal damage, surface blebbing and apoptosis are hindered by α-tocopherol in cultured human keratinocvtes. Eur J Dermatol 1996; 6: 414-420.
158. Yuan X M, Olsson A G, Brunk U T. Macrophage erythrophagocytosis and iron exocytosis. Redox Rep 1996; 2: 9-17.
159. Hebbel R P, Miller W J. Unique promotion of erythrophagocytosis by malondialdehyde. Am J Hematol 1988; 29: 222-225.
160. Baker M S, Gebicki J M. The effect of pH on the conversion of superoxide to hydroxyl free radicals. Arch Biochem Biophys 1984; 234: 258-264.
161. Kennedy K A, McGurt J D, Leonardaridis L, Alabaster O. pH dependence of mitomycin C-induced cross-linking activity in EMT6 tumor cells. Cancer Res 1985; 45: 3541-3547.
162. Wu M-L, Tsai K-L, Wang S-M, Wu J-C, Wang B-S, Lee Y-T. Mechanism of hydrogen peroxide and hydroxyl free radical-induced intracellular acidification in cultured rat cardiac myoblasts. Circ Res 1996; 78: 564-572.
163. - generation. Lab Invest 1988; 58: 448-453.